| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3377325 | Journal of Infection and Chemotherapy | 2011 | 4 Pages |
Abstract
In an analysis of methicillin-resistant Staphylococcus aureus (MRSA) infected patients treated with arbekacin (ABK) only, Gram-negative bacteria (GNB) that were inhibited by low minimal inhibitory concentrations (MICs) of amikacin (AMK) or gentamycin (GM) were eradicated by the end of the ABK treatment. On the other hand, GNB that were only inhibited by high MICs of AMK or GM persisted until the end of treatment with ABK only. Thus, ABK can be expected to be effective even in cases of mixed infection with GNB and MRSA.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
